Blood Plasma Market 2025–2035: Key Segments, Growth Trends, and Risk Analysis

Last Updated:2026년 3월 3일
Publish Date:2026년 3월 3일
Base Year:2026
Format:
Industry - Healthcare & Pharmaceuticals
Forecast Period:2025-2035
Report ID:SYNRPT6328831
Number Of Pages:
TOC:TOC included

Introduction

The global blood plasma market is expanding rapidly due to rising plasma-derived therapies and rising prevelance of immune-mediated disorders. Increasing investments from healthcare providers and favorable regulatory frameworks enhance market growth. This report offers in-depth information on market drivers, segment evaluation, competitive dynamics, and regional prospects—providing businesses with the insights and strategic viewpoints necessary to streamline operations, focus on innovation, build collaborations, and improve market standing in this changing industry

Key Report Highlights

Projected Growth: The Blood Plasma Market is expected to experience consistent growth at a CAGR of 10.5% over the forecast period, achieving $ 85.45 Billion.

Dominant Segments

In the blood plasma market, the immunoglobulin segment dominates the global market as immunoglobulins have broad clinical applications in treating autoimmune disorders. Their established role in standard treatment protocols, expanding off-label uses underpin their leading market share.

Competitive Intelligence

The blood plasma market competition is driven by R&D investment, manufacturing capacity expansion, and acquisitions into emerging markets to capture growing demand. Additionally regional and niche players are increasingly focus on plasma collection and fractionation technologies remain key sources of competitive advantage.

Strategic Insights

Expansion of plasma collection networks and improving donor engagement programs are key strategies used by market players. Focusing on plasma-derived therapies drives demand.

Regional Dynamics

The blood plasma market is largest in North America, followed by Europe. Asia‑Pacific is the fastest-growing region due to increasing plasma collection and demand for plasma-derived therapies. Latin America and Middle East & Africa have smaller shares with emerging adoption and developing healthcare infrastructure.

Advance Therapeutics and Healthcare Solutions through Blood Plasma Market Insights

image 1 alt

Understanding the global Blood Plasma Market is essential in today’s healthcare and biopharmaceutical landscape, where plasma-derived therapies, safety standards, and regulatory compliance drive patient care and industry growth.

image 2 alt
This report highlights key trends, growth drivers, and emerging opportunities, helping organizations adopt advanced plasma collection and processing technologies, optimize therapeutic production, improve treatment availability, and maximize returns on investments in plasma-based healthcare solutions.

image 3 alt

Market Scope & Analysis

ATTRIBUTE
DETAILS
Study Period
2021-2034
Market Base Year
2026
Estimated Year
2026
Forecast Period
2025-2035
Historical Period
2021-2024
Growth Rate
CAGR of 10.5%
Market size value in 2025
$ 36.94 Billion
Market size value by 2035
$ 85.45 Billion
Segmentation Covered
  • Primary Research: Insights from stakeholders such as industry experts, manufacturers, and solution providers.
  • Secondary Research: Review of credible sources including company disclosures, industry reports, and public datasets.
  • Data Triangulation & Validation: Cross-checking inputs and assumptions to ensure consistency and reliability.
Market Leaders
Market Leaders
  • CSL Behring
  • Grifols
  • Octapharma
  • Takeda (Shire)
  • Sanquin
Regions & Countries Covered
Regions & Countries Covered
  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East
  • Africa
  • United States
  • Canada
  • Germany
  • United Kingdom
  • France
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Brazil
  • Mexico
  • United Arab Emirates
  • Saudi Arabia

Recent Developments

Recent Developments

December 2025: In response to the growing demand for plasma-derived products, Takeda Pharmaceutical opened new plasma donation facilities in North America to broaden its network of plasma collecting facilities and boost the availability of plasma for its immunology and rare disease treatments.

November 2025: In order to increase its presence in Europe and provide a more varied and trustworthy pool of plasma donors for fractionation and plasma-derived treatments, Grifols successfully acquired Biotest AG's European plasma collecting activities.

FAQ

A1: Blood Plasma Market expects a CAGR of 10.5% from 2025 to 2035.

A2: The Blood Plasma Market is primarily driven by applications in plasma-derived therapeutics, immunoglobulin therapies, clotting factor treatments, albumin production, and transfusion and regenerative medicine.

A3: Key players in the Blood Plasma Market include CSL Behring, Grifols, Octapharma, Takeda Pharmaceutical (Shire), Baxter International, Kedrion Biopharma, Sanquin Plasma Products, Biotest AG, and LFB Group — major producers and suppliers of plasma‑derived therapies and biotherapeutics.

A4: Challenges in adoption of blood plasma are supply chain and donor limitations, high processing and storage costs, risk of contamination, strict regulatory requirements, and short shelf life.

A5: The Blood Plasma Market is expected to grow fastest in Asia‑Pacific, driven by expanding plasma collection and processing facilities, rising healthcare expenditure, and increasing demand for plasma‑derived therapies.

A6: Blood Plasma Market verticals include hospitals, blood banks, plasma centers, and pharmaceutical companies collecting and processing plasma for transfusions and plasma-derived therapies.

Seize Tomorrow's Opportunities Today: Access the Full Report

Our Top Selling Reports

Personalize This Report

  • •Triangulate with your Own Data
  • •Get Data as per your Format and Definition
  • •Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • •Any level of Personalization

Let Us Help You

  • •What are the Known and Unknown Adjacencies Impacting the Digital Health Market
  • •What will your New Revenue Sources be?
  • •Who will be your Top Customer; what will make them switch?
  • •Defend your Market Share or Win Competitors
  • •Customized Workshop Request